Camp4 Therapeutics (CAMP) Operating Income (2023 - 2026)
Camp4 Therapeutics (CAMP) posted Operating Income of -$13.1 million for Q1 2026, down 2.31% sequentially from -$12.8 million in Q4 2025, and little changed YoY from -$13.0 million in Q1 2025.
Camp4 Therapeutics (CAMP) Operating Income (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has reported Operating Income for 4 years, with the latest figure at -$13.1 million in Q1 2026.
- Quarterly Operating Income changed 0.22% year-over-year to -$13.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$52.5 million (up 1.47% YoY) and the FY2025 annual result came in at -$52.6 million, up 1.0% from the prior year.
- Operating Income slipped to -$13.1 million in Q1 2026 per CAMP's latest filing, from -$12.8 million in the prior quarter.
- Over five years, Operating Income peaked at -$12.3 million in Q3 2023 and troughed at -$14.0 million in Q4 2024.
- A 4-year average of -$13.1 million and a median of -$13.1 million in 2026 frame the typical range for Operating Income.
- The sharpest annual moves came in 2024 and 2025: Operating Income fell 9.55% in 2024, then grew 8.96% in 2025.
- Over 4 years, Operating Income stood at -$13.5 million in 2023, then decreased by 4.14% to -$14.0 million in 2024, then increased by 8.96% to -$12.8 million in 2025, then dropped by 2.31% to -$13.1 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered -$13.1 million, -$12.8 million, and -$13.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,158.03 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Camp4 Therapeutics | 282.48 Mn | 282.48 Mn | - | -13.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.38 Mn |
| Mar 31, 2026 | -13.07 Mn |
| Dec 31, 2025 | -12.78 Mn |
| Sep 30, 2025 | -13.65 Mn |
| Jun 30, 2025 | -13.03 Mn |
| Mar 31, 2025 | -13.10 Mn |
| Dec 31, 2024 | -14.03 Mn |
| Sep 30, 2024 | -13.52 Mn |
| Jun 30, 2024 | -12.66 Mn |
| Mar 31, 2024 | -12.88 Mn |
| Dec 31, 2023 | -13.48 Mn |
| Sep 30, 2023 | -12.34 Mn |